New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration
As part of this expanded visibility initiative, BitMine Immersion Technologies will be featured across New to The Street's multi-platform media network. Coverage includes exclusive interviews, national broadcast segments, and a dedicated NewsOut™ Video Press Release, which will be distributed across over 3 million YouTube subscribers, major business media platforms, and social media syndication on X, LinkedIn, Instagram, and Facebook.
This announcement comes on the heels of BitMine's strategic pivot to become one of the world's largest publicly traded holders of Ethereum (ETH). With the appointment of Tom Lee, Founder of Fundstrat and globally respected macro strategist, as Chairman of the Board, BitMine is redefining its identity from a mining operator to a bold digital asset treasury company.
The NewsOut segment will feature a concise visual summary of BitMine's latest developments, including its Ethereum strategy, capital raise, and leadership shift. In tandem, full-length interviews will be broadcast on Bloomberg and Fox Business, bringing BitMine's story directly to retail and institutional investors alike.
Coverage Includes:
Televised Interview Broadcasts: Bloomberg (Saturday 6:30 PM EST) & Fox Business (Monday 10:30 PM EST)NewsOut Video Press Release: Distributed via YouTube, X, LinkedIn, and financial news wiresSocial Media Amplification: 30 days of digital promotion across New to The Street's channelsEarned Media Syndication: Sent to ABC, NBC, and CBS financial affiliates nationwide
As BitMine accelerates its Ethereum acquisition strategy, investor interest continues to surge, with shares rising over 1,000% in the past week.
For more information on BitMine Immersion Technologies Inc., visit: bitminetech.ioTo watch the NewsOut Video Press Release and broadcast segments, subscribe to: www.YouTube.com/@NewToTheStreetTV
About New to The Street
Where Innovation Meets Influence
New to The Street is one of the most recognized and enduring business television brands in the U.S., delivering award-winning sponsored programming on premier networks including Fox Business and Bloomberg Television. With 3+ million YouTube subscribers, 18 years of uninterrupted broadcasting, and a growing global footprint, we serve as the definitive media platform for both emerging and established public companies.
Each week, we feature long-form interviews with CEOs, visionaries, and market leaders-filmed from the floors of the New York Stock Exchange, the Nasdaq MarketSite, and other iconic financial centers. Our content is further amplified across national television, NYC's most prominent billboards, and a 500,000+ follower investor-focused social media network across X, LinkedIn, Facebook, and Instagram.
We don't just offer visibility-we deliver Opportunity Awareness™. Whether spotlighting biotech innovation or blockchain transformation, New to The Street provides the credibility, scale, and distribution to elevate companies-and inform investors-at the moments that matter most.
New to The StreetTrusted. Syndicated. Unrivaled.
www.NewToTheStreet.comYouTube: @NewtotheStreetTV
Media Contact:Monica BrennanDirector of Media Relations, New to The StreetMonica@NewToTheStreet.com
SOURCE: New To The Street
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Analyst downgrades top S&P 500 stock after disappointing earnings
Analyst downgrades top S&P 500 stock after disappointing earnings originally appeared on TheStreet. Compass Point has lowered Coinbase's (Nasdaq: COIN) price target from $330 to $248 and downgraded the rating from "Neutral" to "Sell" after the crypto exchange reported disappointing financial results for the second quarter of 2025. The investment firm indicated receding retail interest, poor Q2 records, weak prospects for recurring revenue lines like subscriptions and custody services the next quarter, and more competition from stablecoin and decentralized finance (DeFi) platforms as the reasons it downgraded the COIN stock's rating. Compass Point also warned of Coinbase's retail trading under pressure despite a bullish crypto market. Notably, retail trading is Coinbase's main profit are two other factors that the firm highlighted as possible risks for Coinbase. One is a potential delay in the CLARITY Act, which deals with classifying the financial status of crypto assets. Another is Coinbase trailing Robinhood (Nasdaq: HOOD) and Kraken in launching stock trading. 'We see limited support for COIN's valuation if crypto markets sell off further,' said Compass Point. Founded in 2012, Coinbase is the largest crypto exchange in the U.S. The company, which went public in April 2021, joined the S&P 500 list in May 2025 — the only crypto stock to be included in the hotly contested list so far. During Q2 2025, the exchange generated $1.5 billion in total revenue, $1.4 billion in net income, and earnings per share (EPS) of $5.14 in Q2. The exchange held 11,776 Bitcoin worth $1.3 billion by the end of the quarter. The COIN stock is trading at $319.55 at the time of writing, up 1.54% a day. Analyst downgrades top S&P 500 stock after disappointing earnings first appeared on TheStreet on Aug 4, 2025 This story was originally reported by TheStreet on Aug 4, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
19 minutes ago
- Newsweek
The Secret Deals Driving Crypto Markets...and Leeching Into Wall Street
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Crypto markets have always been volatile. For years, we've blamed speculation, low liquidity and hype cycles for the whiplash pricing of altcoins (crypto tokens outside of the leading digital assets Bitcoin, Ethereum and Solana). But there's an opaque force that exerts just as much influence: private market-making agreements. These deals often determine which tokens thrive and which collapse. And over the years, there have been far more failures than successes. Now, Wall Street firms are accelerating their exposure to crypto, investing in increasingly fringe assets and even adding them to corporate treasuries. Public companies Strategy (MSTR) and Metaplanet (3350.T) have amassed holdings of nearly $73 billion and $2 billion, respectively, and scores of other corporations have followed suit. These companies are stepping into markets governed not by transparent rules or familiar oversight, but by unseen, off-chain contracts. A failure to understand how crypto market-making works will distort valuations, mislead investors and potentially spark a backlash that could ripple across both Web3 and traditional finance. From left: Summer Mersinger, CEO, Blockchain Association; Sarah Reilly, vice president and senior tax counsel, Fidelity Investments, Alison Mangiero, head of staking policy and industry affairs, Crypto Council for Innovation; Jason Somensatto, director of policy,... From left: Summer Mersinger, CEO, Blockchain Association; Sarah Reilly, vice president and senior tax counsel, Fidelity Investments, Alison Mangiero, head of staking policy and industry affairs, Crypto Council for Innovation; Jason Somensatto, director of policy, Coin Center; and Corey Frayer, director of investor protection Consumer Federation of America, at the witness table during a House Ways and Means Oversight Subcommittee hearing on "Making America the Crypto Capital of the World: Ensuring Digital Asset Policy Built for the 21st Century" on Capitol Hill on July 16, 2025, in Washington. More AP Photo/Rod Lamkey Jr. I've Seen Behind the Market-Making Curtain Most people assume altcoins are volatile because they're illiquid or built on shaky fundamentals. That's partly true. But what's often overlooked is the influence of market makers—the firms responsible for ensuring there's enough liquidity to buy and sell these tokens in the first place. Unlike their Wall Street counterparts, crypto market makers operate with little to no regulatory oversight. Their agreements are not public. There are no standardized disclosures, no audit trails and no governing body to hold them accountable. Over the past decade, I've helped structure and manage market-making relationships at two of the largest global crypto exchanges, AscendEx and Gemini. I've also led FBG Capital, one of the major market-making firms in the space. Today, I run Forgd, a platform that helps token projects track market maker performance and negotiate better terms. Here's what I've seen: Most token founders are builders, not traders. They lack the financial background to assess how these contracts function, or how damaging they can be when incentives are misaligned. The result is often a one-sided deal, disguised as a liquidity solution, that leaves the project exposed and retail investors misled. The most common—and most problematic—structure is known as the "loan + call option" agreement. The Deal That Quietly Derails Crypto Tokens In a "loan + call option" agreement, a project lends its native tokens to a market maker, who agrees to provide liquidity. In return, the market maker receives call options: the right, but not the obligation, to repay those token loans in U.S. dollars, at a set strike price. If the token's price spikes, the market maker cashes in, buying tokens at a steep discount and selling into the rally. But even if the token flounders, the market maker may still profit by selling the borrowed tokens early, withdrawing support, or shorting the asset outright. The project suffers, but the counterparty walks away profitable. If this happened in traditional equity markets, it would be a scandal. Imagine a company IPO'ing on the NYSE, while a private actor had a backroom deal to dump discounted shares—without any disclosure to the public. Equities have protections for this exact reason. The Securities Exchange Act of 1934 outlines clear boundaries designed to prevent manipulation during public offerings: Regulation M governs stabilization activity and passive market making, helping to ensure that prices aren't artificially inflated, while Rule 10b-18 provides a safe harbor for stock buybacks, shielding companies from accusations of market manipulation when repurchasing their own shares. Crypto has no equivalent safeguards. And as more institutional capital enters the space, this lack of structure is becoming a systemic risk. Wall Street Is Next It's no longer just crypto-native funds or retail investors buying these assets. We're now seeing mainstream firms and institutional allocators adding altcoins to their balance sheets, sometimes without full visibility into how these markets actually function. That's dangerous. When token prices are being influenced by off-chain, through asymmetric contracts that no one outside the deal has access to, it undermines the integrity of the asset and misleads downstream investors. A market's fundamentals might appear sound, when in fact they're propped up by short-term gamesmanship and opaque incentives. If left unchecked, this could discredit digital assets at a moment when they're finally being taken seriously. It also opens the door to backlash from regulators and shareholders if firms suffer losses tied to undisclosed risk mechanics they never knew existed. For crypto to mature as a credible, investable asset class, we need to bring these agreements out of the shadows and into the realm of professional accountability. Founders need tools to benchmark proposed deals, simulate different scenarios, and negotiate on informed terms. Regulators, fund managers and institutional allocators should insist on basic transparency before engaging with new assets. At a minimum, every market-making arrangement should include standardized disclosures that outline the structure of the agreement governing liquidity. These disclosures should make clear whether call options are involved, specify the strike prices and loan tenor associated with those options, and describe any hedging policies that may impact token performance. Without this level of transparency, investors and project teams are left to navigate blind, with little understanding of the dynamics shaping token markets. These are table stakes. Without them, we're asking sophisticated firms to operate in the dark, and exposing retail investors to risks they never signed up for. If digital assets are going to sit on the balance sheets of public companies, the rules that govern those assets can't be locked behind NDAs. They need sunlight, structure and scrutiny. Otherwise, we risk importing the worst parts of crypto into the heart of Wall Street—and learning too late that we could have done better. Shane Molidor is the founder and CEO of Forgd, a token advisory and optimization platform that provides seamless access to essential tools for blockchain projects.
Business Upturn
21 minutes ago
- Business Upturn
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe
Concept Medical announces first patient enrollment in MAGICAL-SV IDE trial, expanding its Coronary Clinical Program across the U.S. and Europe. Business Wire India Concept Medical Inc. , a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA's IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical's mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. Dr. Samin Sharma enrolled the first patient at New York's Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatment options for patients with small-vessel coronary artery disease. 'Today marks a great feat for us and for the MAGICAL-SV trial,' said Dr. Samin Sharma. 'My team at Mount Sinai is privileged to be the first to begin this study. This is a proud moment for all of us, especially knowing what the trial signifies and aims to achieve by evaluating MagicTouch as a potential alternative for treating small vessels in the U.S.' Concept Medical is now actively enrolling in three IDE trials concurrently in the U.S., across coronary and peripheral interventions, underscoring its commitment to bringing innovative therapies to patients worldwide. MAGICAL-SV is a prospective, multicenter, single-blind randomized trial (2:1 randomization) comparing Concept Medical's MagicTouch sirolimus-coated balloon to DES (Everolimus eluting stents [EES] or Zotarolimus eluting stents [ZES]) for the treatment of small coronary artery lesions. Randomization is stratified by study site and presence of medically-treated diabetes mellitus status. The trial will enroll 1,605 patients across the U.S. and Europe, to evaluate the primary endpoint of target lesion failure (TLF) at 12 months. An international team of renowned cardiologists, Dr. Martin B. Leon (USA) – Study Chair, with principal investigators (PI) Dr. Azeem Latib (USA), Dr. Ajay Kirtane (USA), and Prof. Antonio Colombo (Europe) will lead the MAGICAL-SV trial. Dr. Azeem Latib, a U.S. PI for MAGICAL-SV, noted, 'The first U.S. patient enrollment in the MAGICAL-SV study marks an exciting step forward in building robust evidence for SCB technology in the treatment of small-vessel coronary disease. As we explore metal-free PCI strategies, this study brings renewed hope for safer, more effective options for our patients.' Prof. Antonio Colombo, who leads the European arm, added, 'Starting small and going big! MAGICAL-SV represents an important step in building evidence for sirolimus-coated balloons.' This milestone embodies a 'leave nothing behind' philosophy in coronary interventions, treating arterial blockages without permanent implants and addressing the limitations of metallic stents in small vessels. Dr. Martin B. Leon, the Study Chair, emphasized evaluating a no-stent strategy through this trial: 'The initiation of the MAGICAL-SV trial marks an important step in evaluating sirolimus-coated balloon therapy for small coronary vessels. By addressing key limitations of stenting in this complex anatomy, the study aims to generate strong comparative data versus DES. The results could inform future treatment strategies in the U.S. and Europe, offering clinicians a potential alternative for managing small-vessel disease.' The pioneering MAGICAL-SV trial aims to yield strong clinical evidence for sirolimus-coated balloon therapy, supporting Pre-Market Approval (PMA) for MagicTouch SCB in small vessels and potentially redefining CAD treatment. Dr. Manish Doshi, Founder and MD of Concept Medical, said, "MAGICAL-SV marks another step in our mission to redefine vascular care. We're focused on delivering next-generation solutions, helping clinicians achieve better outcomes and give CAD patients a better quality of life." For media inquiries contact: [email protected] Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
